Greek justice minister vows speedy corruption inquiry

January 3, 2017

Greece's justice minister on Tuesday promised a "swift and thorough" investigation into suspected corruption by civil servants and Swiss pharmaceutical giant Novartis.

Stavos Kontonis ordered an inquiry after "denunciations concerning bribes paid to functionaries by Novartis" appeared in the press, a ministerial statement said.

"The judicial investigation will be swift and thorough," it added.

According to a judicial source, a preliminary investigation has been going on for two months and around 178 people in Greece have been questioned.

The source said anti-corruption prosecutors had visited Novartis's premises near Athens to gather evidence.

The case gained attention in recent days following a suicide attempt in Athens on Sunday, New Year's Day, by a Novartis manager.

That attempt was thwarted by police and according to the judicial source, the manager was one of those questioned over corruption.

For its part Novartis issued a statement saying it was "aware of the media reports about our business practices" in Greece and that it was seeking more information and was cooperating with the authorities.

"Novartis is committed to the highest standards of ethical business conduct and regulatory compliance in all aspects of its work and takes any allegation of misconduct extremely seriously," the company said in the statement.

The judicial source also claimed American FBI agents were in Athens to help Greek authorities investigate Novartis.

The Swiss pharmaceutical giant was investigated by US authorities in 2014, accused of paying bribes in order to boost sales of some of its medicines, and was later fined $390 million by the US Justice Department.

Explore further: Novartis Korea executives charged for bribing doctors

Related Stories

Novartis Korea executives charged for bribing doctors

August 13, 2016
Prosecutors have indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for ...

Novartis could face S.Korea sales ban amid corruption allegations: media

August 11, 2016
Swiss pharmaceutical giant Novartis risks seeing some of its medicines banned in South Korea after company executives were charged with offering illegal discounts to doctors, the Financial Times reported Thursday.

Novartis probes corruption claims in Chinese press

September 18, 2013
Swiss pharmaceutical giant Novartis announced Tuesday it has opened an internal inquiry following Chinese press accusations of corruption at its Alcon eye care division.

Novartis sees 20 percent income fall due to strong dollar

July 21, 2015
Swiss pharmaceutical giant Novartis reported $4.1 billion (3.8 billion euros) in income for the first half of the year, down 20 percent, due largely to a stronger dollar.

US seeks $3.3 bn corruption fine from Novartis

July 1, 2015
US authorities are seeking up to $3.3 billion (three billion euros) in fines from Swiss pharmaceutical giant Novartis on allegations it paid kickbacks to boost drug sales, according to a document AFP consulted Wednesday.

Novartis acquires US pharma research firm Selexys Pharmaceuticals

November 21, 2016
Swiss-based pharmaceuticals giant Novartis said Monday it was acquiring Selexys Pharmaceuticals Corp., a US research lab in blood and inflammatory disorders, in a deal costing up to $665 million (627 million euros).

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.